Irish biopharma company and UCD to use gene therapy for rare skin disorder – Siliconrepublic.com
Siliconrepublic.com |
Irish biopharma company and UCD to use gene therapy for rare skin disorder
Siliconrepublic.com With the aim of developing a treatment for a rare and debilitating skin disorder, an Irish biopharma company and UCD have signed a gene therapy licencing deal. Amryt, the Irish-listed biopharma company that focuses on rare and so-called 'orphan … Amryt licenses gene therapy platform; refines its Phase III EASE study of AP101 Amryt reports strong 2017 as revenues rise to almost €13m Irish company focused on bad cholesterol treatment sees revenue increase to €13m |
